7 Healthy Medical Stocks to Buy

11:42am, Tuesday, 09'th Feb 2021
Some medical stocks gained momentum because of the pandemic, while others focus on high-reward challenges like cancer treatment. The post 7 Healthy Medical Stocks to Buy appeared first on InvestorPlac

Why Cardiff Oncology Ran Up 1,350% in 2020

07:00am, Sunday, 31'st Jan 2021
This cancer specialist is looking to defeat the KRAS mutation.

The 17 Stocks That Outperformed Tesla In 2020

11:54am, Thursday, 21'st Jan 2021
This article looks at the 17 companies listed on U.S. exchanges that had a higher total return than high-flying Tesla in 2020. The stocks tended to be microcap to small cap stocks in sectors that piqu
Investors need to pay close attention to Cardiff Oncology (CRDF) stock based on the movements in the options market lately.

CRDF Stock Price Fell 31.22%: Why It Happened

04:13am, Monday, 18'th Jan 2021
The stock price of Cardiff Oncology Inc (NASDAQ: CRDF) fell by 31.22% on Friday, January 15. This is why it happened.

Why Cardiff Oncology Stock Is Crashing Today

12:10pm, Friday, 15'th Jan 2021
The biotech presented data from an early-stage study of its experimental colorectal cancer drug.

My Favorite Biotech Stock for 2021

10:00am, Monday, 04'th Jan 2021
This clinical-stage biotech stock could be a top buyout candidate in 2021.
These clinical-stage drug developers were unstoppable last year.
The biopharma sector weathered the COVID-19 pandemic fairly well, with the Shares Nasdaq Biotechnology Etf (NASDAQ: IBB) outperforming the S&P 500 Index. This defensive sector also benefited from oppo
These stocks have made investors richer by posting explosive revenue growth or advancing significantly in high-impact programs.
The highest performers of the year are biotechs fighting COVID-19 and cancer. Are they still buys for 2021?

These Were the 5 Best Cancer Stocks Of 2020

08:29am, Monday, 07'th Dec 2020
Biotech investors had more than just vaccines to think about this year.
SAN DIEGO, Dec. 6, 2020 /PRNewswire/ -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company developing drugs to treat cancers with the greatest medical need for new treatment
We are initiating coverage of Cardiff Oncology (CRDF) with a "VERY BULLISH" rating at a 30 PT. We project a worldwide peak sales north of US$1bn for mCRC indication only. CRDF shares have been steadil
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 19) 10X Genomics Inc (NASDAQ: TXG) ALX Oncology Holdings Inc (NASDAQ: ALXO) Avenue Therapeutics Inc (NASDAQ: ATXI)...
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE